152
Views
36
CrossRef citations to date
0
Altmetric
REVIEW

There's plenty of room at the forum: Potential risks and safety assessment of engineered nanomaterials

, , , , , & show all
Pages 73-84 | Published online: 10 Jul 2009

References

  • Andersen HC. 1835. [Fairy tales, Told for Children]. [Danish].
  • Ashwood P, Thompson RP, Powell JJ. Fine particles that adsorb lipopolysaccharide via bridging calcium cations may mimic bacterial pathogenicity towards cells. Exp Biol Med 2007; 232: 107–117
  • Bath J, Turberfield AJ. DNA nanomachines. Nat Nanotech 2007; 2: 275–284
  • Brown JS, Zeman KL, Bennett WD. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 2002; 166: 1240–1247
  • Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Curr Opin Biotechnol 2007; 18: 26–30
  • Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005; 1: 325–327
  • Cullen RT, Tran CL, Buchanan D, Davis JM, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol 2000; 12: 1089–1111
  • Dockery DW. Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ Health Perspect 2001; 109: 483–486
  • Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006; 92: 5–22
  • Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. Nanotoxicology. Occup Environ Med 2004; 261: 727–728
  • Duffin R, Gilmour PS, Schins RP, Clouter A, Guy K, Brown DM, MacNee W, Borm PJ, Donaldson K, Stone V. Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-κB activation. Toxicol Appl Pharmacol 2001; 176: 10–17
  • Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdörster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006; 114: 1172–1178
  • Environmental Protection Agency. 2007. U.S. Environmental Protection Agency Nanotechnology White Paper. Science Policy Council, Environmental Protection Agency.
  • European Commission 2005. Nanosciences and Nanotechnologies: An Action Plan for Europe 2005–09. Communication from the Commission to the Council, the European Parliament and the Economic and Social committee.
  • European Group on Ethics in Science and New Technologies to the European Commission. 2007. Opinion on the Ethical Aspects of Nanomedicine. Opinion No. 21.
  • Fadeel B, Kagan VE. Apoptosis and macrophage clearance of neutrophils: regulation by reactive oxygen species. Redox Rep 2003; 8: 143–150
  • Ferin J, Oberdörster G, Soderholm SC, Gelein R. Pulmonary tissue access of ultrafine particles. J Aerosol Med 1991; 4: 57–68
  • Feynman RP. 1960. There's plenty of room at the bottom: An invitation to enter a new field of physics. Engineering & Science 23 (22 Feb).
  • Gerber C, Lang HP. How the doors to the nanoworld were opened. Nat Nanotech 2006; 1: 3–5
  • Gieseking R. [Absorption and deposition of foreign substances in the lung based on electron optic examination]. [German]. Ergeb Allg Pathol Pathol Anat 1958; 38: 92–126
  • Gwinn MR, Vallyathan V. Nanoparticles: Health effects-pros and cons. Environ Health Perspect 2006; 114: 1818–1825
  • Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-ß1 secretion and the resolution of inflammation. J Clin Invest 2002; 109: 41–50
  • Kagan VE, Bayir H, Shvedova AA. Nanomedicine and nanotoxicology: Two sides of the same coin. Nanomedicine 2005; 1: 313–3136
  • Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenström-Magnusson C, Liu SX, Serinkan FB, Arroyo A, Chandra J, Orrenius S, Fadeel B. A role for oxidative stress in apoptosis: Oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J Immunol 2002; 169: 487–499
  • Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, Schwegler-Berry D, Mercer R, Castranova V, Shvedova AA. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol Lett 2006; 165: 88–100
  • Kuempel ED, Tran CL, Castranova V, Bailer AJ. Lung dosimetry and risk assessment of nanoparticles: Evaluating and extending current models in rats and humans. Inhal Toxicol 2006; 18: 717–724
  • Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: From toxicology to pharmacology. Adv Drug Deliv Rev 2006; 58: 1460–1470
  • Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 2006; 36: 189–217
  • LeDuc PR, Wong MS, Ferreira PM, Groff RE, Haslinger K, Koonce MP, Lee WY, Love JC, McCammon JA, Monteiro-Riviere NA, Rotello VM, Rubloff GW, Westervelt R, Yoda M. Towards an in vivo biologically inspired nanofactory. Nat Nanotech 2007; 2: 3–7
  • Lundborg M, Dahlen SE, Johard U, Gerde P, Jarstrand C, Camner P, Låstbom L. Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages. Environ Res 2006; 100: 197–204
  • Maynard AD, Aitken RJ. Assessing exposure to airborne nanomaterials: Current abilities and future requirements. Nanotoxicology 2007; 1: 26–41
  • Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB. Safe handling of nanotechnology. Nature 2006; 444: 267–269
  • Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM, Cassee FR, Boon NA, Macnee W, Millar AM, Donaldson K, Newby DE. Do inhaled carbon nanoparticles translocate directly into the circulation in humans?. Am J Respir Crit Care Med 2006; 173: 426–431
  • Moghimi SM, Hunter AC, Murray JC. Nanomedicine: Current status and future prospects. FASEB J 2005; 19: 311–330
  • Möller W, Felten K, Seitz J, Sommerer K, Takenaka S, Wiebert P, Philipson K, Svartengren M, Kreyling WG. A generator for the production of radiolabelled ultrafine carbonaceous particles for deposition and clearance studies in the respiratory tract. J Aerosol Sci 2006; 37: 631–644
  • Monteiller C, Tran L, Macnee W, Faux SP, Jones AD, Miller BG, Donaldson K. 2007. The pro-inflammatory effects of low solubility low toxicity particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 18 Apr [Epub ahead of print].
  • Monteiro-Riviere NA, Inman AO. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006; 44: 1070–1078
  • Nel A. Air pollution-related illness: effects of particles. Science 2005; 308: 804–806
  • Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006; 311: 622–627
  • Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 2002; 105: 411–414
  • Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 1992; 97: 193–199
  • Oberdörster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102 Suppl. 1994; 5: 173–179
  • Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113: 823–839
  • Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004; 16: 437–445
  • Oberdörster G, Stone V, Donaldson K. Toxicology of nanoparticles: A historical perspective. Nanotoxicology 2007; 1: 2–25
  • Orrenius S, Zhivotovsky B. The future of toxicology – does it matter how cells die?. Chem Res Toxicol 2006; 19: 729–733
  • Pekkanen J, Peters A, Hoek G, Tiittanen P, Brunekreef B, de Hartog J, Heinrich J, Ibald-Mulli A, Kreyling WG, Lanki T, Timonen KL, Vanninen E. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease. The Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air [ULTRA] study. Circulation 2002; 106: 933–938
  • Peters A, Dockery DW, Heinrich J, Wichmann HE. Short-term effects of particulate air pollution on respiratory morbidity in asthmatic children. Eur Respir J 1997a; 10: 872–879
  • Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am Respir Crit Care Med 1997b; 155: 1376–1383
  • Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 2007; 168: 58–74
  • Roco MC. Nanotechnology: convergence with modern biology and medicine. Curr Opin Biotechnol 2003; 14: 337–346
  • The Royal Society and The Royal Academy of Engineering (RS/RAE) 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties LondonUnited Kingdom: RS/RAE.
  • Schmid G, Brune H, Ernst H, Grünwald W, Grünwald A, Hofmann H, Janich P, Krug HF, Mayor M, Rathgeber W, Simon U, Vogel V, Wyrwa D. 2006. Nanotechnology. Assessment and perspectives Berlin: Springer.
  • Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 2005. The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. European Commission Health & Consumer Protection Directorate-General.
  • Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289: L698–L708
  • Shvedova AA, Kisin ER, Murray AR, Gorelik O, Arepalli S, Castranova V, Young SH, Gao F, Tyurina YY, Oury TD, Kagan VE. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol Appl Pharmacol 2007; 221: 339–348
  • Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006; 103: 3357–3362
  • Toumey C. Thesis: Plenty of eyes at the bottom. Nat Nanotech 2007; 2: 192–193
  • Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 2000; 12: 1113–1126
  • United States Congress Joint Economic Committee (JEC) Study. 2007. Nanotechnology: The future is coming sooner than you think Washington, DC: JEC.
  • Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, Scheynius A, Gabrielsson S. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett 2006; 6: 1682–1686
  • Wang H, Wang J, Deng X, Sun H, Shi Z, Gu Z, Liu Y, Zhao Y. Biodistribution of carbon single-wall carbon nanotubes in mice. J Nanosci Nanotechnol 2004; 4: 1019–1024
  • Wiebert P, Sanchez-Crespo A, Falk R, Philipson K, Lundin A, Larsson S, Kreyling W, Möller W, Svartengren M. No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol 2006a; 18: 741–747
  • Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling W, Möller W, Sommerer K, Larsson S, Svartengren M. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J 2006b; 28: 286–290
  • Wörle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 2006; 6: 1261–1268

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.